Monica E. Bonilla

ORCID: 0000-0002-1936-3712
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune cells in cancer
  • Phagocytosis and Immune Regulation
  • Chemokine receptors and signaling
  • Cancer Research and Treatments
  • Epigenetics and DNA Methylation
  • Nanoparticle-Based Drug Delivery
  • Pancreatic and Hepatic Oncology Research
  • Fibroblast Growth Factor Research
  • Macrophage Migration Inhibitory Factor
  • Ferroptosis and cancer prognosis
  • Cancer Cells and Metastasis
  • Liver Disease Diagnosis and Treatment
  • Diet and metabolism studies

University of Michigan–Ann Arbor
2023

Michigan Medicine
2022

Abstract Pancreatic ductal adenocarcinoma (PDA) continues to have a dismal prognosis. The poor survival of patients with PDA has been attributed high rate early metastasis and low efficacy current therapies, which partly result from its complex immunosuppressive tumor microenvironment. Previous studies our group others shown that tumor-associated macrophages (TAM) are instrumental in maintaining immunosuppression PDA. Here, we explored the role Notch signaling, key regulator immune response,...

10.1158/2326-6066.cir-23-0037 article EN Cancer Immunology Research 2023-11-06

Abstract Purpose: Pancreatic ductal adenocarcinoma (PDAC) is generally divided in two subtypes, classical and basal. Recently, single-cell RNA sequencing has uncovered the coexistence of basal cancer cells, as well intermediary individual tumors. The latter remains poorly understood; here, we sought to characterize them using a multimodal approach. Experimental Design: We performed subtyping on dataset containing 18 human PDAC samples identify multiple subtypes. generated patient-derived...

10.1158/1078-0432.ccr-23-1421 article EN cc-by-nc-nd Clinical Cancer Research 2023-10-18

<div>Abstract<p>Pancreatic ductal adenocarcinoma (PDA) continues to have a dismal prognosis. The poor survival of patients with PDA has been attributed high rate early metastasis and low efficacy current therapies, which partly result from its complex immunosuppressive tumor microenvironment. Previous studies our group others shown that tumor-associated macrophages (TAM) are instrumental in maintaining immunosuppression PDA. Here, we explored the role Notch signaling, key...

10.1158/2326-6066.c.7005663 preprint EN 2024-01-03

<div>Abstract<p>Pancreatic ductal adenocarcinoma (PDA) continues to have a dismal prognosis. The poor survival of patients with PDA has been attributed high rate early metastasis and low efficacy current therapies, which partly result from its complex immunosuppressive tumor microenvironment. Previous studies our group others shown that tumor-associated macrophages (TAM) are instrumental in maintaining immunosuppression PDA. Here, we explored the role Notch signaling, key...

10.1158/2326-6066.c.7005663.v1 preprint EN 2024-01-03
Coming Soon ...